Anonymous ID: ff6c30 Feb. 12, 2020, 12:42 p.m. No.8115984   🗄️.is 🔗kun   >>6040 >>6175 >>6289 >>6346

>>8114574 - Q Stringer 10387

>https://www.sec.gov/Archives/edgar/data/83246/000114420418002250/0001144204-18-002250.txt

 

Sorry anons, haven't checked breads since to see if there's been further discussion. Looking through the html formatting I've extracted some text but I've got to workfag so I've got to stop. Here's what I've extracted so far;

 

"The Buffered Autocallable Yield Notes (each 'Note'; and collectively the 'Notes') offered hereunder will not be listed on any U.S. securities exchange or automated quotation system. The Notes will not bear interest.

Neither the U.S. Securities and Exchange Commission (the 'SEC') nor any state securities commission has approved or disapproved of the Notes or passed upon the accuracy or the adequacy of this document, the accompanying prospectus, prospectus supplement, Equity Index Underlying Supplement or ETF Underlying Supplement. Any representation to the contrary is a criminal offense.

We have appointed HSBC Securities (USA) Inc., an affiliate of ours, as the agent for the sale of the Notes. HSBC Securities (USA) Inc. will purchase the Notes from us for distribution to other registered broker-dealers or will offer the Notes directly to investors. HSBC Securities (USA) Inc. or another of its affiliates or agents may use the pricing supplement to which this free writing prospectus relates in market-making transactions in any Notes after their initial sale. Unless we or our agent informs you otherwise in the confirmation of sale, the pricing supplement to which this free writing prospectus relates is being used in a market-making transaction. See 'Supplemental Plan of Distribution (Conflicts of Interest)'; on page FWP-17 of this free writing prospectus.

Investment in the Notes involves certain risks. You should refer to 'Risk Factors' beginning on page FWP-9 of this document, page S-1 of the accompanying prospectus supplement, page S-2 of the accompanying Equity Index Underlying Supplement and page S-1 of the accompanying ETF Underlying Supplement.

The Estimated Initial Value of the Notes on the Pricing Date is expected to be between $970 and $1,000 per Note, which may be less than the price to public. The market value of the Notes at any time will reflect many factors and cannot be predicted with accuracy. See 'Estimated Initial Value' on page FWP-5 and 'Risk Factors' beginning on page FWP-9 of this document for additional information."